![]() |
市場調査レポート
商品コード
1630656
腎結石管理市場規模、シェア、成長分析、タイプ別、治療タイプ別、診断別、エンドユーザー別、地域別 - 産業予測、2025-2032年Kidney Stones Management Market Size, Share, Growth Analysis, By Type (Calcium Oxalate Stones, Uric Acid), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy), By Diagnosis, By End User, By Region - Industry Forecast 2025-2032 |
||||||
|
腎結石管理市場規模、シェア、成長分析、タイプ別、治療タイプ別、診断別、エンドユーザー別、地域別 - 産業予測、2025-2032年 |
出版日: 2025年01月07日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
腎結石管理の世界市場規模は2023年に20億6,000万米ドルと評価され、2024年の22億米ドルから2032年には37億9,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは7.0%で成長する見通しです。
世界の腎結石管理市場は、世界の腎臓結石症例の増加によって力強い成長を遂げています。回復を促進し、不快感を最小限に抑える衝撃波結石破砕術、尿管鏡検査、経皮的腎結石除去術などの先進技術を活用した革新的な治療オプションに対する需要が高まっています。市場は、レーザー結石破砕術やロボット支援手術を含む低侵襲技術への傾倒を強めており、正確な標的を確実に定めて患者の転帰を改善しています。さらに、再発防止や疼痛緩和を目的とした新薬の研究開発も進んでいます。高い普及率と支援的な費用償還政策により北米が優勢ではありますが、アジア太平洋地域は、ヘルスケア・インフラと認知度の向上に後押しされ、最も速い成長を示すと予測されます。全体として、この市場は技術の進歩と戦略的な地域拡大によって有望な軌道を描いています。
Global Kidney Stones Management Market size was valued at USD 2.06 billion in 2023 and is poised to grow from USD 2.2 billion in 2024 to USD 3.79 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).
The Global Kidney Stones Management Market is experiencing robust growth, driven by a rising incidence of kidney stone cases globally. There is an escalating demand for innovative treatment options, leveraging advanced technologies like shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy that enhance recovery and minimize discomfort. The market is increasingly leaning towards minimally invasive techniques, including laser lithotripsy and robotic-assisted surgeries, which ensure precise targeting and improved patient outcomes. Additionally, substantial research and development efforts are yielding new pharmaceuticals aimed at preventing recurrence and alleviating pain. Dominated by North America due to high prevalence and supportive reimbursement policies, the Asia-Pacific region is predicted to exhibit the fastest growth, propelled by enhanced healthcare infrastructure and awareness. Overall, this market demonstrates a promising trajectory marked by technological advancement and strategic regional expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Kidney Stones Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Kidney Stones Management Market Segmental Analysis
Global Kidney Stones Management Market is segmented by Type, Treatment Type, Diagnosis, End User and region. Based on Type, the market is segmented into Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones and Calcium Phosphate Stones. Based on Treatment Type, the market is segmented into Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy and Percutaneous Nephrolithotomy. Based on Diagnosis, the market is segmented into Specialty Ultrasound, Intravenous Pyelography, CT Scan, X-Ray and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Kidney Stones Management Market
A major driver of the Global Kidney Stones Management Market is the escalating incidence of kidney stone cases across the globe. The rising number of individuals affected by this condition is creating an urgent need for effective treatment solutions, thereby fueling advancements in medical technology and innovative procedures. As more people face challenges related to kidney stones, there is heightened attention towards research and development to enhance current treatment methodologies and unveil new interventions. This growing prevalence not only highlights the necessity for better management options but also propels market expansion as healthcare providers strive to meet the increasing demand for reliable kidney stone therapies.
Restraints in the Global Kidney Stones Management Market
A significant challenge facing the Global Kidney Stones Management Market is the elevated costs linked to specific treatment procedures and technologies. Although advanced options, like robotic-assisted surgeries and laser lithotripsy, provide substantial advantages in precision and patient outcomes, their high price can be prohibitive. Furthermore, many of these advanced treatments may lack availability or insurance coverage in certain areas, restricting access for patients with limited financial means. This financial barrier can impede the broader acceptance and implementation of advanced treatment methods, consequently affecting the overall growth potential of the market.
Market Trends of the Global Kidney Stones Management Market
The Global Kidney Stones Management market is witnessing a significant trend towards the increasing adoption of robotic-assisted surgeries for kidney stone removal. Innovations in robotic platforms, like Ethicon's MONARCH system, are becoming increasingly favored in urology for their precision and ability to minimize procedural complications. By integrating advanced robotic technologies, surgeons can execute more accurate and controlled maneuvers, which leads to improved patient outcomes and decreased rates of retreatment. This trend underscores the industry's commitment to harnessing cutting-edge technology, enhancing the overall efficacy and safety of kidney stone management procedures, and ultimately transforming patient care in this field.